2Whelton PK,Williamson JD,Louis GT,et al.Experimental approaches to determining the choice of first-step therapy for patients with hypertension.The ALLHAT Research Group Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial[J].Clin Exp Hypertens,1996,18(3-4):569-579.
4Reyes AJ.Diuretics in the therapy of hypertension[J].J Hum Hypertens,2002,16:S78-S83.
5Yamato M,Sasaki T,Honda K,et al.Effects of torasemide on left ventricular function and neurohumoral factors in patients with chronic heart failure[J].Circ J,2003,67(5):384-390.Erratum in:Circ J,2003,67(6):565;Circ J,2003,67(7):649.
6Muller K,Gamba G,Jaquet F,et al.Torasemide vs.furosemide in primary care patients with chronic heart failure NYHA Ⅱ to Ⅳ-efficacy and quality of life[J].Eur Heart Failure,2003,5(6):793-801.
1[1]Hansson L, Zanchetti A, Carruthers SG, et al. Effects of intensive blood - pressure lowering and low - dose aspirin in patient with hypertension :principal results of the Hypertension Optimal Treatment(HOT) randomized trial. Lancet, 1998,351: 1755~1762
2[2]The SHEP Cooperative Research Group, JAMA, 1991,265:3255
3[4]WHO - ISH guidelines for the management of hypertension. J Hypertens,1999,17:151~183
4[7]CIBIS Ⅱ Investigators and Committees. The cardiac insufficiency bisoprolol study Ⅱ: A randomised trial. Lancet, 1999,353:9~13
5[8]Hansson L, Lindholm LH, Niskanen L, et al. Effect of ACEI compared with conventional therapy on cardiovascular morbidity and mortality in hypertension. The Captopril Prevention Project (CAPPP) randomized trial. Lancet, 1999,353: 611
6[9]Yusuf S, Sleight P, Pogue J, et al. Effect of an ACEI ramipril, on cardiovascular events in high - risk pt. The HOPE Investigators. New E J MED,2000,342:145
7Consensus recommendations for the management of chronic heart failure.On behalf of the membership of the advisory council to improve outcomes nationwide in heart failure[].The American Journal of Cardiology.1999